SEC Form 4 · accession 0000899243-18-006636
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adelene Q Perkins
Officer — Chief Executive Officer · Director
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2018 | S | 5,000 | $2.778 | D | 607,252 | D | |
| Common Stock | holding | — | — | — | 12,391 | I | 401(K) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017.